Allos Therapeutics (NGM: ALTH) NewsBite - FDA Approves ALTH's Folotyn

Posted: Friday, September 25, 2009 10:53 AM EDT

Allos Therapeutics (NGM: ALTH) opened at $8.55. So far today, the stock has hit a low of $8.11 and a high of $8.66. ALTH is now trading at $8.32, up $0.17 (2.09%). Over the last 52 weeks the stock has ranged from a low of $3.82 to a high of $9.30. ALTH shares are on the move today after the FDA approved its injectable drug Folotyn as a treatment for peripheral T-cell lymphoma. Technical indicators for the stock are neutral and S&P does not currently have a STARS rating for ALTH. If you are looking for a hedged play on ALTH the stock seems like it could be a candidate for a November out-of-the-money bull-put credit spread below the 7.50 range. [ABR-Seven Summits Strategic Investments NewsBite]

Click Symbol For More News On: (ALTH)